BCL2 and acute myeloid leukemia: Together, these findings argue that TPL and ABT-199 might interact to induce robust apoptosis and overcome resistance to each single drug through disruption of the compensatory responses to these agents alone by simultaneously downregulation of antiapoptotic Bcl-2 family proteins and upregulation of proapoptotic BH3-only proteins in AML cells.